0001209191-20-055390.txt : 20201020 0001209191-20-055390.hdr.sgml : 20201020 20201020171643 ACCESSION NUMBER: 0001209191-20-055390 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201013 FILED AS OF DATE: 20201020 DATE AS OF CHANGE: 20201020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Szekeres David Leslie CENTRAL INDEX KEY: 0001602459 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33221 FILM NUMBER: 201248898 MAIL ADDRESS: STREET 1: C/O REGULUS THERAPEUTICS INC. STREET 2: 3545 JOHN HOPKINS COURT, SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/ CENTRAL INDEX KEY: 0000818033 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942875566 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582514400 MAIL ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: AP PHARMA INC /DE/ DATE OF NAME CHANGE: 20010511 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19920703 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-10-13 0 0000818033 HERON THERAPEUTICS, INC. /DE/ HRTX 0001602459 Szekeres David Leslie 4242 CAMPUS POINT COURT SUITE 200 SAN DIEGO CA 92121 0 1 0 0 EVP, Chief Operating Officer Common Stock 3571 D Employee Stock Option (Right to Buy) 16.20 2026-03-17 Common Stock 170000 D Employee Stock Option (Right to Buy) 16.83 2026-10-07 Common Stock 50000 D Employee Stock Option (Right to Buy) 13.00 2026-12-21 Common Stock 79167 D Employee Stock Option (Right to Buy) 17.00 2027-12-18 Common Stock 90000 D Employee Stock Option (Right to Buy) 24.97 2028-12-15 Common Stock 92000 D Employee Stock Option (Right to Buy) 25.02 2029-12-19 Common Stock 115000 D Employee Stock Option (Right to Buy) 15.72 2030-10-13 Common Stock 156000 D Restricted Stock Units 0.00 Common Stock 20000 D The stock option is fully vested and exercisable. The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant. The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant. /s/ Lisa Peraza Attorney-in-fact for David Szekeres 2020-10-20 EX-24.3_942031 2 poa.txt POA DOCUMENT POWER OF ATTORNEY I hereby constitute and appoint Lisa Peraza as my true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Heron Therapeutics, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Act"), and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action in connection with the foregoing which, in the opinion of such attorney-in-fact, is intended to benefit, is in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve. The undersigned hereby grants to each attorney-in-fact full power and authority to do and perform any act requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all the acts such attorney-in-fact shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that each foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming any of the undersigned's responsibilities to comply with Section 16 of the Act. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date set forth below. By: /s/ David Szekeres Print Name: David Szekeres Date: 10/14/2020